Document ID: chunk:federal_register_of_legislation:F2025C00124:reg:7
Version: federal_register_of_legislation:F2025C00124
Segment Type: reg
Provision Reference: reg 7
Character Range: 18048–20592

7  Definition of authorised prescriber

Specialists affiliated with hospitals
 (1) A specialist is an authorised prescriber for an HSD pharmaceutical benefit for a patient receiving treatment in, at or from a hospital if the specialist is affiliated with the hospital.

Medical practitioners—with the agreement of specialists
 (2) A medical practitioner is an authorised prescriber for an HSD pharmaceutical benefit for a patient receiving treatment in, at or from a hospital if all of the following apply:
 (a) the benefit is for continuing treatment for the patient;
 (b) the patient's treatment is being managed by a specialist;
 (c) it is impractical for the patient to obtain a prescription for the benefit from the specialist;
 (d) the specialist has agreed to the prescribing of the benefit for the patient by the medical practitioner.

Medical practitioners—if authorised by Commonwealth and State authorities
 (3) A medical practitioner is an authorised prescriber for an HSD pharmaceutical benefit for a patient if all of the following apply:
 (a) the HSD pharmaceutical benefit is for continuing treatment for the patient;
 (b) the medical practitioner is authorised (however described) by an authority of the Commonwealth for the purposes of this provision;
 (c) the medical practitioner is authorised (however described) by an authority of the State or Territory in which the hospital is located for the purposes of this provision.

Medical practitioners—medication for the treatment of hepatitis C, lanreotide and octreotide
 (4) A medical practitioner is an authorised prescriber for the following HSD pharmaceutical benefits:
 (a) a benefit that has a drug that is a medication for the treatment of hepatitis C;
 (b) a benefit that has the drug lanreotide;
 (c) a benefit that has the drug octreotide, if:
 (i) the description of its form includes "Injection (modified release)"; and
 (ii) it is for continuing treatment.

Accredited prescribers—HSD pharmaceutical benefits for the treatment of hepatitis B, hepatitis C, HIV or AIDS, and schizophrenia
 (5) The following table has effect.

Authorised prescribers for certain HSD pharmaceutical benefits
Item                                                            Column 1                                                                   Column 2
                                                                The following person …                                                     is an authorised prescriber for an HSD pharmaceutical benefit that has a drug that is …